Navigation Links
Scientists discover why cornea is transparent and free of blood vessels, allowing vision

lage), is the thin transparent tissue that covers the front of the eye. It is the clarity of the cornea that allows light to pass onto the retina and from there to the brain for interpretation. When the cornea is clouded by injury, infection or abnormal blood vessel growth, vision is severely impaired, if not destroyed.

Scientists have been wrestling with the "clarity" puzzle for many decades. And, while some previous studies have revealed small clues, none have pointed to one major mechanism, until this study.

In most other tissues of the body, blood vessel growth or angiogenesis occurs in response to a need for increased blood flow to heal an injured or infected area. The immune system sends in growth factors such as vascular endothelial growth factor (VEGF) to bind with a protein receptor called VEGFR-2 on blood vessels to trigger vessel growth. Three forms of VEGF--A, C, and D--bind with this receptor. Two of them, C and D also bind with VEGFR-3, which is usually found on cells lining lymphatic vessels, to stimulate the growth of lymphatic vessels.

Dana's team began to suspect the involvement of VEGFR-3 in stopping blood growth in corneas when they noticed unexpectedly that large amounts of the protein seemed to exist naturally on healthy corneal epithelium, a previously unknown location for the receptor. Dana and his team were already aware from clinical experience that the epithelium most likely played a role in suppressing blood vessel growth on the cornea, having witnessed blood vessels develop on corneas stripped of their epithelial layers.

They began to theorize that the large amounts of VEGFR-3, in this new, non-vascular location, might be attracting and sucking up all the C and D VEGF growth factors, thereby blocking them from binding with VEGFR-2. And, because this binding took place in a non-vascular setting, the growth factors were neutralized.

To test their theory, the team conducted a series of experimen
'"/>

Source:Schepens Eye Research Institute


Page: 1 2 3

Related biology news :

1. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
2. Scientists Replicate Hepatitis C Virus in Laboratory
3. Scientists detect probable genetic cause of some Parkinsons disease cases
4. Scientists find missing enzyme for tuberculosis iron scavenging pathway
5. Scientists seek answers on what activates deadly anthrax spores
6. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
7. Scientists collaborate to assess health of global environment
8. Scientists decipher genome of fungus that can cause life-threatening infections
9. Scientists discover the cellular roots of graying hair
10. Scientists rid stem cell culture of key animal cells
11. Scientists develop new color-coded test for protein folding

Post Your Comments:
(Date:11/20/2009)...n, Mass., November 19, 2009 The estimated 4.6 mil... be at risk of developing respiratory symptoms due...a questionnaire study undertaken earlier this year...chool of Veterinary Medicine. , The studywhich p...ound that 50 percent of individuals working in bar...
(Date:11/20/2009)...ass from the production of flax shives, and genera...ant related to those which engulf fields in spring... suggested by two studies carried out by Spanish a... Renewable and Sustainable Energy Reviews . , "Th...of view, the production of bioethanol from two, as...
(Date:11/19/2009)...ghly 15,000 years ago, at the end of the last ice ...als including such iconic creatures as mammoths, ... beavers began their precipitous slide to extinct...ing a land whose diversity of large animals equale...ains then or now, an entirely novel ecosystem emer...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Flax and yellow flowers can produce bioethanol 2After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies 13513 1Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies 13513 2Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies 13513 3Suicide Risk With Antidepressants Falls With Age 54272 1Suicide Risk With Antidepressants Falls With Age 54272 2Suicide Risk With Antidepressants Falls With Age 54272 3HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 1HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 2HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 3HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 4
..., researchers watched patiently as a few computer-...e than 15,000 slightly different shapes. In real t...cond. In the end, however, this suspended animatio...al new drug target to fight drug-resistant AIDS. ...s made the discovery while studying how one rare s...
...ning fat, insects and mammals may have something i... Cell Metabolism. The study finds that the so-call...te of genes involved in determining the fates of m...in fat formation in both flies and mice. The findi...nes on fat storage from insects to mammals, accord...
...d that worms dwelling at deep-sea hydrothermal ven...113-131 degrees Fahrenheit) when given a choice of...rence of any animal studied to date. This unique p...rsea worms, meal ticket, since they are apparently...- lush mats of bacteria that thrive around deep-se...
Other Biology News:Computer simulation hints at new HIV drug target 2Computer simulation hints at new HIV drug target 3Computer simulation hints at new HIV drug target 4Computer simulation hints at new HIV drug target 5Insects and mammals share common fat-building pathway, study suggests 2Some like it hot: Worms at deep-sea vents favor a fiery 45-55°C 2
(Date:11/19/2009)...Austria, November 19 AFFiRiS AG wi...oduct candidate at an unexpectedly early,stage of ... to enter into,Phase II clinical trial early in 20...ws the completion of two Phase I trials with the c...t decision on the first interim,analysis of the se...
(Date:11/18/2009)...ed to be able to find explosive materials and pers...h searches, the National Institute of Standards an...ent of Homeland Security, has developed a new cert...ial (SRM) 2905, Trace Particulate Explosives. Comp...e SRM will be helpful in calibrating, testing and ...
(Date:11/18/2009)...., Nov. 18 Sangamo BioSc... data from the University of Pennsylvania investig...inc finger nuclease (ZFN) based product, SB-728-T,...isclosed on the internet. ,, Data were presente...vania School of Medicine from a single subject tre...
(Date:11/18/2009)...West Sussex, U.K. and CLEVELAND, Nov. 18 /PRNewswi...nces business and premier provider of diagnostic s...y labs, has expanded its East Grinstead, U.K., man...o meet increasing global demand for its Sensititre...ication testing. The expanded facility has been fu...
Breaking Biology Technology:AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New NIST trace explosives standard slated for homeland security duty 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4
...xas, Nov. 20 Wound Care,Innovations, LLC, a subsi...M),announced today a published case demonstrating ... product, CellerateRx(R). The case was presented ...nagement in the special section,Diabetic Wound Car...ns from,APWCA, APWCA Case #1: Using Combined Treat...
..., Nov. 20 A US District Court,judge in Oregon yes...r of,Smith & Nephew,s (NYSE: SNN ; LSE: SN) ...vately held Arthrex Inc. of Naples, Fla., from man...e a patent exclusively licensed to Smith &,Nep... injunction takes effect,60 days following the fin...
.... 20 Cyntellect, a privately-held life,sciences c...on of live cell,analysis, manipulation and purific... a research collaboration agreement with the Univ...otechnology Research. The agreement will focus,on...ation and analysis of,cancer stem cells (CSCs), ra...
Other Biology Technology:Wound Management Technologies, Inc. Announces a Published Case Study 2Wound Management Technologies, Inc. Announces a Published Case Study 3US District Court Enters Final Judgment in Favor of Smith & Nephew; Permanent Injunction Prohibits Arthrex Inc. From Selling Infringing Medical Devices 2US District Court Enters Final Judgment in Favor of Smith & Nephew; Permanent Injunction Prohibits Arthrex Inc. From Selling Infringing Medical Devices 3University of Florida and Cyntellect Collaborate to Unlock Mysteries of Cancer Stem Cells 2University of Florida and Cyntellect Collaborate to Unlock Mysteries of Cancer Stem Cells 3
...first fully automated proteomics workcell. It inte...with complete data tracking. It automates the enti...through final protein expression and measurement. ...g a plate to any of its instruments from any other...
... software for life science applications on the GEN...ION instruments including the Te-MO multichannel p...r the simple graphical configuration of the system...ul scripting language the most flexible and comple...
Transfection Buffer from BD Biosciences Pharmingen
SYBR Green I Nucleic Acid Gel Stain from Roche Applied Science
Biology Products: